About 11,755 results

ALLMedicine™ Hyperparathyroidism Center

Research & Reviews  3,882 results

Clinical and Economic Evaluation of Ultrasound-Guided Radiofrequency Ablation vs. Parat...
Academic Radiology; Chai HH, Dai ZJ et. al.

Mar 26th, 2023 - To compare the clinical and economic effects of ultrasound (US)-guided radiofrequency ablation (RFA) with parathyroidectomy (PTX) for primary hyperparathyroidism (PHPT). From April 2014 to April 2021, 123 PHPT patients who received US-guided RFA o...

Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Endocrine Reviews; Jha S, Simonds WF

Mar 25th, 2023 - Recent data suggest an increase in the overall incidence of parathyroid disorders with primary hyperparathyroidism (PHPT) being the most prevalent parathyroid disorder. PHPT is associated with morbidities (fractures, kidney stones, chronic kidney ...

Androgen therapy does not prevent bone loss and arterial calcifications in male rats wi...
The Journal of Endocrinology; David K, Dubois V et. al.

Mar 24th, 2023 - Patients suffering from chronic kidney disease (CKD) often experience bone loss and arterial calcifications. It is unclear if hypogonadism contributes to the development of these complications, and whether androgen therapy might prevent them. Male...

Opportunistic CT Assessment of Parathyroid Glands: Utility of Radiologist-Recommended B...
AJR. American Journal of Roentgenology; Bunch PM, Aribindi S et. al.

Mar 23rd, 2023 - Background: Existing gaps in primary hyperparathyroidism (PHPT) diagnosis and treatment have prompted calls for systemic change in the approach to this disease. One proposed change is opportunistic assessment for enlarged parathyroid glands on rou...

Complex Regional Pain Syndrome Type 1 (Reflex Sympathetic Dystrophy) Medication

Mar 21st, 2023 - Medication Summary Several drugs, either alone or in combination with sympathetic blockade, may be efficacious in prolonging the duration of symptomatic relief. Some of these drugs reduce the activity of the sympathetic nervous system, whereas oth...

see more →

Guidelines  6 results

ACR Appropriateness Criteria® Parathyroid Adenoma.
Journal of the American College of Radiology : JACR; , Zander D et. al.

Nov 20th, 2021 - Hyperparathyroidism is defined as excessive parathyroid hormone production. The diagnosis is made through biochemical testing, in which imaging has no role. However, imaging is appropriate for preoperative parathyroid gland localization with the i...

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of workin...
Journal of Nephrology; Bellasi A, Cozzolino M et. al.

Dec 20th, 2019 - Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a lar...

National Osteoporosis Society vitamin D guideline summary.
Age and Ageing; Aspray TJ, Bowring C et. al.

Jul 31st, 2014 - The National Osteoporosis Society (NOS) published its document, Vitamin D and Bone Health: A Practical Clinical Guideline for Patient Management, in 2013 as a practical clinical guideline on the management of vitamin D deficiency in adult patients...

AME position statement: primary hyperparathyroidism in clinical practice.
Journal of Endocrinological Investigation; Zini M, Attanasio R et. al.

Jul 25th, 2012 - AME position statement: primary hyperparathyroidism in clinical practice.|2012|Zini M,Attanasio R,Cesareo R,Emmolo I,Frasoldati A,|therapeutic use,etiology,therapeutic use,therapeutic use,complications,diagnosis,drug therapy,surgery,etiology,blood,

European League Against Rheumatism recommendations for calcium pyrophosphate deposition...
Annals of the Rheumatic Diseases; Zhang W, Doherty M et. al.

Jan 11th, 2011 - To agree terminology and to develop recommendations for the diagnosis of calcium pyrophosphate deposition (CPPD). The European League Against Rheumatism (EULAR) CPPD Task Force, comprising 15 experts from 10 countries, agreed the terms and recomme...

see more →

Drugs  180 results see all →

Clinicaltrials.gov  366 results

Natural History Study of Children and Adults With Medullary Thyroid Cancer

Mar 17th, 2023 - Background: Medullary Thyroid Carcinoma (MTC) is a calcitonin producing tumor arising from the parafollicular C cells of thyroid. In children and adults, MTC is usually seen in association with Multiple Endocrine Neoplasia (MEN) 2A and 2B, which a...

Glycemic Control, Type II Diabetes, Parathyroidectomy

Mar 9th, 2023 - Primary hyperparathyroidism (PHPT) is known to affect the kidney and skeletal system, however, recent data have suggested that patients can also exhibit an increased cardiovascular risk and metabolic abnormalities Primary hyperparathyroidism (PHPT...

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Feb 27th, 2023 - The main objective of this study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9 years with SHPT associated with stage 5 CKD receiving Peritoneal Dialysis (PD) or Hemo...

Circulating miRNA in Primary Hyperparathyroidism

Feb 24th, 2023 - Osteoporosis and osteopenia are chronic diseases disproportionately affecting the elderly. In the United States, the prevalence of osteoporosis is projected to increase from 10 million in 2005 to 14 million in 2025, due to population aging. Simila...

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Feb 24th, 2023 - This is a phase 3, multi-center, randomized, double-blind, placebo-controlled study in children with stage 3-4 chronic kidney disease (CKD), secondary hyperparathyroidism (SHPT) and vitamin D insufficiency.

see more →

News  235 results

Rybelsus Now OK'd in First Line; Menopause Before Transition; Novel T2D Drug Flops

Jan 17th, 2023 - Oral semaglutide (Rybelsus) received an expanded label to include first-line treatment for adults with type 2 diabetes as an adjunct to diet and exercise, Novo Nordisk announced. The Obesity Society and Obesity Action Coalition lent support to the...

New Hypercalcemia Guideline; Untreated Hyperparathyroidism Risky; PFAS Phase-Out

Dec 27th, 2022 - The Endocrine Society released new guidelines for treating hypercalcemia of malignancy in adults. (The Journal of Clinical Endocrinology & Metabolism) Childhood cancer survivors -- especially females -- may carry an increased risk for fractures. (...

Lithium-associated hypercalcemia: Monitoring and management
Sumeet Gupta, MD, Adityo Khastgir, MBBS

Dec 1st, 2022 - Hypercalcemia is a well-known but underrecognized adverse effect of lithium. Most patients with lithium-associated hypercalcemia (LAH) have either nonspecific symptoms (eg, persistent tiredness, constipation, polyuria, polydipsia) or no symptoms.

Tender Nonhealing Lesion on the Leg
Austinn C. Miller, MD, Mojahed Mohammad K. Shalabi, MD et. al.

Sep 28th, 2022 - The Diagnosis: Calciphylaxis Calciphylaxis is a rare life-threatening condition that most often is seen in patients with end-stage renal disease at a rate of 35 per 10,000 chronic dialysis patients. 1 It less commonly has been described in nonuremi.

Endo Case Challenge: Rash, Brain Fog, and Sleep Issues in a 50-Year-Old IT Director

Aug 19th, 2022 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

see more →

Patient Education  33 results see all →